BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
GTS |
|
Gilles de la Tourette syndrome
|
|
|
0.682 |
0.615 |
MAA |
|
microphthalmia or anophthalmia and associated anomalies
|
|
|
0.666 |
0.577 |
SAA3P |
|
serum amyloid A3, pseudogene
|
|
|
0.722 |
0.500 |
ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
LOH19CR1 |
|
loss of heterozygosity, 19, chromosomal region 1
|
|
|
0.569 |
0.808 |
PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
RNU1-1 |
|
RNA, U1 small nuclear 1
|
|
|
0.608 |
0.731 |
MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
H19 |
|
H19 imprinted maternally expressed transcript
|
|
|
0.494 |
0.923 |
NEAT1 |
|
nuclear paraspeckle assembly transcript 1
|
|
|
0.502 |
0.769 |
MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
MIRLET7B |
|
microRNA let-7b
|
|
|
0.493 |
0.769 |
MIR10A |
|
microRNA 10a
|
|
|
0.513 |
0.846 |
MIR125A |
|
microRNA 125a
|
|
|
0.480 |
0.769 |
MIR126 |
|
microRNA 126
|
|
|
0.447 |
0.846 |
MIR140 |
|
microRNA 140
|
|
|
0.522 |
0.769 |
MIR142 |
|
microRNA 142
|
|
|
0.480 |
0.846 |
MIR143 |
|
microRNA 143
|
|
|
0.462 |
0.885 |